Concept of combinatorial de novo design of drug-like molecules by particle swarm optimization

Chem Biol Drug Des. 2008 Jul;72(1):16-26. doi: 10.1111/j.1747-0285.2008.00672.x. Epub 2008 Jun 13.

Abstract

We present a fast stochastic optimization algorithm for fragment-based molecular de novo design (COLIBREE, Combinatorial Library Breeding). The search strategy is based on a discrete version of particle swarm optimization. Molecules are represented by a scaffold, which remains constant during optimization, and variable linkers and side chains. Different linkers represent virtual chemical reactions. Side-chain building blocks were obtained from pseudo-retrosynthetic dissection of large compound databases. Here, ligand-based design was performed using chemically advanced template search (CATS) topological pharmacophore similarity to reference ligands as fitness function. A weighting scheme was included for particle swarm optimization-based molecular design, which permits the use of many reference ligands and allows for positive and negative design to be performed simultaneously. In a case study, the approach was applied to the de novo design of potential peroxisome proliferator-activated receptor subtype-selective agonists. The results demonstrate the ability of the technique to cope with large combinatorial chemistry spaces and its applicability to focused library design. The technique was able to perform exploitation of a known scheme and at the same time explorative search for novel ligands within the framework of a given molecular core structure. It thereby represents a practical solution for compound screening in the early hit and lead finding phase of a drug discovery project.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms*
  • Combinatorial Chemistry Techniques*
  • Cross-Linking Reagents
  • Drug Design*
  • Ligands
  • Models, Molecular*
  • Peroxisome Proliferator-Activated Receptors / agonists

Substances

  • Cross-Linking Reagents
  • Ligands
  • Peroxisome Proliferator-Activated Receptors